- Home
- AUB vs VKTX Comparison
AUB vs VKTX Comparison
Compare AUB & VKTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AUB
- VKTX
- Stock Information
- Founded
- AUB 1902
- VKTX 2012
- Country
- AUB United States
- VKTX United States
- Employees
- AUB N/A
- VKTX N/A
- Industry
- AUB Major Banks
- VKTX Biotechnology: Pharmaceutical Preparations
- Sector
- AUB Finance
- VKTX Health Care
- Exchange
- AUB Nasdaq
- VKTX Nasdaq
- Market Cap
- AUB 3.5B
- VKTX 2.8B
- IPO Year
- AUB N/A
- VKTX 2015
- Fundamental
- Price
- AUB $29.40
- VKTX $27.85
- Analyst Decision
- AUB Buy
- VKTX Buy
- Analyst Count
- AUB 5
- VKTX 12
- Target Price
- AUB $39.00
- VKTX $84.00
- AVG Volume (30 Days)
- AUB 1.9M
- VKTX 4.4M
- Earning Date
- AUB 04-24-2025
- VKTX 04-23-2025
- Dividend Yield
- AUB 4.61%
- VKTX N/A
- EPS Growth
- AUB N/A
- VKTX N/A
- EPS
- AUB 2.15
- VKTX N/A
- Revenue
- AUB $797,879,000.00
- VKTX N/A
- Revenue This Year
- AUB $78.93
- VKTX N/A
- Revenue Next Year
- AUB $15.95
- VKTX N/A
- P/E Ratio
- AUB $13.71
- VKTX N/A
- Revenue Growth
- AUB 16.62
- VKTX N/A
- 52 Week Low
- AUB $22.85
- VKTX $18.92
- 52 Week High
- AUB $44.54
- VKTX $81.81
- Technical
- Relative Strength Index (RSI)
- AUB 59.18
- VKTX 54.95
- Support Level
- AUB $28.42
- VKTX $26.73
- Resistance Level
- AUB $29.64
- VKTX $30.28
- Average True Range (ATR)
- AUB 0.87
- VKTX 1.66
- MACD
- AUB 0.59
- VKTX 0.37
- Stochastic Oscillator
- AUB 95.74
- VKTX 65.19
About AUB Atlantic Union Bankshares Corporation
Atlantic Union Bankshares Corp is a financial holding company and a bank holding company. Through its community bank subsidiary, the company provides financial services, including banking, trust, and wealth management. The bank is a full-service community bank offering consumers and businesses a wide range of banking and related financial services, including checking, savings, certificates of deposit, and other depository services, as well as loans for commercial, industrial, residential mortgage, and consumer purposes. The company operates through two reportable operating segments: Wholesale Banking and Consumer Banking, with corporate support functions such as corporate treasury and others included in Corporate Other. It derives maximum revenue from Wholesale Banking.
About VKTX Viking Therapeutics Inc.
Viking Therapeutics Inc is a healthcare service provider. The company specializes in the area of biopharmaceutical development focused on metabolic and endocrine disorders. The company's clinical program pipeline consists of VK2809, VK5211, VK0214 products. VK2809 and VK0214 are orally available, tissue and receptor-subtype selective agonists of the thyroid hormone receptor beta. VK5211 is an orally available, non-steroidal selective androgen receptor modulator.